Fig. 6From: A novel epigenetic signature for overall survival prediction in patients with breast cancerValidation of the signature in three external cohorts. Patients with a low risk score showed better OS in the validation cohorts GSE20685 (a), GSE86948 (b) and GSE17907 (c). Patients with a low risk score showed better RFS in the validation cohort GSE12093 (d)Back to article page